Albuterol/Ipratropium Nebulizer Solution 0.5-3Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Albuterol/Ipratropium: Nebulizer solution (0.5-3mg)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png
Ipratrop/Albut 0.5-3mg/3ml Inh
Drug Image file default-drug-image.png
Ipratrop/Albut 0.5-3mg/3ml Inh
Drug Image file default-drug-image.png
Ipratrop/Albut 0.5-3mg/3mL Inh
Drug Image file default-drug-image.png
Ipratrop/Albut 0.5-3mg/3ml Inh
Drug Image file default-drug-image.png
Ipratrop/Albut 0.5-3mg/3ml Inh

What is this Medicine?

ALBUTEROL; IPRATROPIUM (al BYOO ter ole; i pra TROE pee um) has two bronchodilators. It helps open up the airways in your lungs to make it easier to breathe. This medicine is used to treat chronic obstructive pulmonary disease (COPD).

Similar Brand Name Drugs : DuoNeb: Nebulizer solution (0.5-3mg)
CVS Pharmacy Patient Statistics for Albuterol/Ipratropium: Nebulizer solution(0.5-3mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Ipratropium Bromide/Albuterol Sulfate 0.5mg-3mg/3ml Solution for Inhalation

NDC: 003789671
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Emphysema, Chronic Obstructive Pulmonary Disease (COPD)

Sometimes used for but not FDA approved for the following conditions:
Asthma

Storage Information
Protect from light
Store between 36 to 77 degrees F
Ipratropium Bromide/Albuterol Sulfate 0.5mg-3mg/3ml Solution for Inhalation
Close All Sections Show

Reported Side Effects for Ipratropium Bromide/Albuterol Sulfate 0.5mg-3mg/3ml Solution for Inhalation

Close Show
Paresthesias Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Mouth Ulcers Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Abnormal Heart Rhythm Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Wheezing Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Constipation Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Painful Urination Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Low Potassium Levels Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Eye Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
0.3-1.9%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
0.3-2.6%*
Severity: MODERATE
Onset: EARLY
Hives Incidence:
0.3%*
Severity: MILD
Onset: RAPID
Itching Incidence:
0.3-1.9%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
0.5%*
Severity: MODERATE
Onset: EARLY
Irregular Heart Beat Incidence:
0.5%*
Severity: SEVERE
Onset: EARLY
Hoarseness Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Rhinitis Incidence:
1.1%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.3-10.9%*
Severity: MILD
Onset: DELAYED
Muscle Cramps Incidence:
1.4%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
1.4-1.9%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
1.4-2.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
2.0-5.6%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
2.0-4.5%*
Severity: MODERATE
Onset: EARLY
Cough Incidence:
2.0-4.2%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
2.2-4.4%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
2.3%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Ipratropium Bromide/Albuterol Sulfate 0.5mg-3mg/3ml Solution for Inhalation
Close Show

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Ipratropium Bromide/Albuterol Sulfate 0.5mg-3mg/3ml Solution for Inhalation(Albuterol Sulfate)
Close Show
Caffeine-containing Foods/Beverages and Beta-agonists(Albuterol Sulfate)
Limit excessive Caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) and limit medicines containing additional Caffeine. In caffeine-sensitive persons, taking a high amount of Caffeine with this drug can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, or other side effects.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Albuterol/Ipratropium

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.